Skip to main content
Special or Theme Issue

Patient Safety Papers.

Ardenne M, Reitnauer PG. [Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20…. Arzneimittel-Forschung. 1975;25(9):1369-79.

Save
Print
November 30, 2005
Ardenne M, Reitnauer PG. Arzneimittel-Forschung. 1975;25(9):1369-79.

This special issue highlights Canadian experiences in several safety-related areas: culture shift in support of safety, risk identification and reduction, medication safety, change initiative strategies, and disclosure and accountability.

Save
Print
Cite
Citation

Ardenne M, Reitnauer PG. [Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20…. Arzneimittel-Forschung. 1975;25(9):1369-79.